Sun Pharma’s Restructuring Drive: 40% Global Workforce Reduction, U.S. Unit Shrinks by 80%

Sun Pharma Advanced Research Company Ltd announced a 40% global workforce reduction, including an 80%+ cut in U.S. staff. The restructuring aims to optimize costs and refocus on priority R&D programs. Analysts view the move as a strategic step to balance innovation with financial sustainability.

Show more

Stay Ahead – Explore Now! Sensex Today: GIFT Nifty Signals Weak Start, Asian Markets Lower